EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Transcription factor EB, a promising therapeutic target in cardiovascular disease

Xin Yan, Li Yang, Xiaolei Fu, Xin Luo, Chengming Wang, Qiu Ping Xie, Fan OuYang

PeerJ · 2024

DOI: 10.7717/peerj.18209 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PeerJ, 2024. Verfasst von Xin Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Autophagy, Lysosomes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) remains the major cause of morbidity and mortality around the world. Transcription factor EB (TFEB) is a master regulator of lysosome biogenesis and autophagy. Emerging studies revealed that TFEB also mediates cellular adaptation responses to various stimuli, such as mitochondrial dysfunction, pathogen infection and metabolic toxin. Based on its significant capability to modulate the autophagy-lysosome process (ALP), TFEB plays a critical role in the development of CVD. In this review, we briefly summarize that TFEB regulates cardiac dysfunction mainly through ameliorating lysosomal and mitochondrial dysfunction and reducing inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsAutophagyLysosomesHumansAnimalsMitochondriaInflammation

Stichwörter der Autor:innen

Autophagic fluxCardiovascular diseaseLysosomeTFEB

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTFEB protein, human

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China.

Zitieren

APA

Yan, X., Yang, L., Fu, X., Luo, X., Wang, C., Xie, Q. P., & OuYang, F. (2024). Transcription factor EB, a promising therapeutic target in cardiovascular disease. PeerJ. https://doi.org/10.7717/peerj.18209

Vancouver

Yan X, Yang L, Fu X, Luo X, Wang C, Xie QP, et al. Transcription factor EB, a promising therapeutic target in cardiovascular disease. PeerJ. 2024. doi:10.7717/peerj.18209

BibTeX
@article{Yan2024,
  author = {Yan, Xin and Yang, Li and Fu, Xiaolei and Luo, Xin and Wang, Chengming and Xie, Qiu Ping and OuYang, Fan},
  title = {Transcription factor EB, a promising therapeutic target in cardiovascular disease},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.18209}
}
Kostenlos starten →